Sulfate is a relatively abundant sulfur compound in the intestinal ecosystem. It can enter the gut through food, host secretions and the activity of other microorganisms. Under oxygen-limited conditions, certain bacteria convert sulfate through a series of reduction reactions, ultimately producing reduced sulfur compounds such as sulfide. These reactions are usually associated with energy conservation or sulfur metabolism. The new work indicates that, in Salmonella, sulfate-reducing systems can have a direct effect on infection biology, linking a basic metabolic pathway to the ability to colonize an animal host.

The researchers focused on enzymes that allow Salmonella to process sulfur compounds in the anaerobic environment of the intestine. Unlike many metabolic enzymes that perform one narrowly defined chemical reaction, the sulfate reductases examined in this study appear to possess catalytic properties that are distinctive from better-characterized counterparts. Their activity can influence the balance between sulfate, sulfite and reduced sulfur products, creating chemical conditions that may benefit Salmonella while disadvantaging competing microbes.

That distinction is important because the intestine is not an empty landscape. It is a densely populated ecosystem in which pathogens must compete with established communities of bacteria for nutrients and attachment sites. During inflammation, the environment changes dramatically: oxygen and alternative electron acceptors become more available, host-derived antimicrobial molecules accumulate and microbial competition intensifies. Salmonella is known to exploit these disturbances, switching on metabolic programs that allow it to grow under conditions that many resident bacteria cannot tolerate. Sulfur metabolism now appears to be part of that adaptive strategy.

In mouse experiments, the investigators compared normal Salmonella with strains carrying genetic disruptions in sulfate-reduction pathways. These altered bacteria were less capable of maintaining robust colonization, indicating that the enzymes were not merely passive components of cellular chemistry. Restoring the relevant activity improved the infection phenotype, supporting the conclusion that the catalytic function itself was important. Such genetic tests are central to distinguishing a correlation between metabolism and disease from a direct contribution to bacterial fitness.

The study also highlights the difference between a gene being present and an enzyme being functionally useful in the gut. A metabolic pathway may be encoded in the genome, but its importance depends on whether its substrates are available, whether the pathway is active under intestinal conditions and whether its products alter the surrounding ecosystem. By examining enzyme activity alongside bacterial genetics and mouse colonization, the researchers connected all three levels: the molecular reaction, the behavior of the bacterium and the outcome of infection.

One possible explanation for the colonization advantage is that sulfur reduction helps Salmonella withstand chemical stress generated during inflammation. Reduced sulfur compounds can react with metals, oxidants and other reactive molecules, potentially changing their toxicity or availability. Sulfur chemistry may also influence neighboring bacteria directly. Even modest changes in sulfide or related compounds could alter respiratory metabolism, enzyme function or sensitivity to antimicrobial conditions across the microbial community. The study suggests that Salmonella benefits not only from using sulfur compounds itself, but also from the ecological effects of the reactions it performs.

The findings may help resolve why sulfur metabolism repeatedly appears in studies of enteric pathogens. In the gut, energy sources are often limited and spatially unevenly distributed. Bacteria that can use alternative chemical reactions gain access to niches unavailable to organisms relying on oxygen or conventional fermentation. Sulfate reduction can provide metabolic flexibility, while its products may simultaneously modify the competitive environment. This combination gives the pathway a dual role: it supports the pathogen’s internal physiology and may influence the broader microbial community outside the cell.

The work could eventually inform new approaches to treating Salmonella infection. Instead of targeting growth-essential processes directly, future therapies might interfere with the pathogen’s ability to manipulate intestinal chemistry. Inhibiting a distinctive sulfate reductase, blocking access to its substrates or neutralizing the ecological effects of its products could weaken colonization without broadly eliminating beneficial gut bacteria. However, translating the result into treatment will require caution. Sulfur compounds are produced and consumed by many organisms, and disrupting these reactions could have consequences for the host microbiome. The immediate significance of the study is therefore mechanistic: it identifies a previously underappreciated route by which Salmonella converts metabolism into an advantage during infection.

More broadly, the study reinforces a central lesson of modern microbiology: pathogens do not colonize the body through virulence factors alone. Their success depends on the ability to sense and modify nutrients, gases, metals and chemical signals within a living ecosystem. By revealing that Salmonella sulfate reductases possess unusual catalytic activity linked to gut colonization, the researchers show how a seemingly ordinary metabolic pathway can become a specialized tool of infection. The discovery raises new questions about whether related enzymes operate in other enteric pathogens and whether sulfur chemistry could be a general battleground between invading bacteria, resident microbes and the host.

Subject of Research: The role of Salmonella sulfate reductases and their distinctive catalytic activity in promoting intestinal colonization in mice.

Article Title: Salmonella uses sulfate reductases with unique catalytic activity to promote gut colonization in mice.

Article References: Kim, JS., Uppalapati, S., Margolis, A. et al. Salmonella uses sulfate reductases with unique catalytic activity to promote gut colonization in mice. Nature Microbiology (2026). https://doi.org/10.1038/s41564-026-02443-y

Image Credits: AI Generated

DOI: https://doi.org/10.1038/s41564-026-02443-y

Keywords: Salmonella, sulfate reductase, sulfur metabolism, gut colonization, intestinal microbiome, bacterial pathogenesis, anaerobic metabolism, mouse infection models, microbial competition, infectious disease

Traditionally, Drosophila has been exploited for its genetic tractability and cost-effectiveness, but inducing host infections has largely relied on invasive techniques such as microinjections. These approaches, while effective for systemic infections, fall short in replicating the intricacies of intestinal colonization and mucosal immunity encountered in clinical scenarios. The transition to a feeding model thus represents a significant leap, allowing researchers to mimic the nuanced steps of bacterial adherence, invasion, and host response within the gut milieu, a critical site of pathogen-host interplay.

The published protocol meticulously outlines the dual preparatory phases: the priming of flies for infection and the culture of bacterial inocula. The latter involves growing P. aeruginosa, a notoriously opportunistic pathogen, to defined concentrations and tailoring the consistency of the infectious mixture. This degree of control is crucial—it enables the modulation of bacterial virulence, a feature that can either exacerbate or abrogate infection outcomes. Such versatility adds layers of experimental finesse, permitting investigations into bacterial load thresholds that can trigger diverse host responses.

Simultaneously, the preparation of adult Drosophila for the feeding assay demands nuanced management of physiological states. Variables such as age, genetic background, and baseline microbiota are carefully standardized, ensuring reproducibility and interpretability of infection phenotypes. This meticulous fly handling culminates in a feeding setup that closely mimics natural exposure routes, facilitating pathogen entry through ingestion, and thereby reflecting infection dynamics more akin to human gastrointestinal encounters with P. aeruginosa.

Outcome assessments post-infection are diverse and extensive, encompassing survival analyses, quantitative bacterial load measurements, systemic spread evaluations, and explorations of intestinal regeneration. These multifaceted readouts furnish a panoramic view of the host-pathogen tug-of-war, revealing insights into virulence factors, host immune defenses, and tissue repair mechanisms. The protocol’s comprehensive design accommodates tens of bacterial species, either singly or in synergy, further broadening its applicability across infectious disease research.

One remarkable feature of this feeding infection protocol lies in its capability to dissect the pathogen’s virulence modulation. The infectious dose’s consistency adjustment essentially allows researchers to dial the infection’s severity, illuminating the thresholds of bacterial pathogenicity and host resilience. This capacity facilitates dissecting not only lethal infection dynamics but also chronic or subclinical manifestations that are critical in understanding persistent infections seen in clinical settings.

The method also pioneers the measurement of bacterial loads within the hemolymph, an analog to the mammalian bloodstream, providing direct evidence of systemic dissemination post-gut infection. This ability to track bacterial translocation from the gut underscores the model’s potential for exploring sepsis and systemic inflammatory responses following breach of epithelial barriers. Coupled with histopathological analyses, particularly in tumor-prone fly lines, researchers gain a granular understanding of intestinal tissue damage, immune cell infiltration, and regenerative responses.

Furthermore, the inclusion of transcriptomic profiling elevates this protocol beyond standard infection assays. By analyzing host gene expression in response to oral P. aeruginosa infection, researchers can decipher molecular pathways triggered during pathogen challenge, delineating immune signaling circuits, stress responses, and metabolic adjustments. This molecular interrogation reveals potential therapeutic targets and host factors critical for defense and tissue homeostasis.

The time frame for preparing flies and bacterial cultures is designed to be efficient yet thorough, spanning a maximum of one week for fly priming and two days for infection mix preparation. This balance ensures high-quality experimental setups without imposing prohibitively long preparative periods, making the protocol accessible to laboratories with standard expertise in microbiology and fly handling. Importantly, the downstream measurements of survival and bacterial load are within reach of researchers after short training, while advanced analyses like histopathology and transcriptomics require a more prolonged commitment to mastery.

Practicality and scalability are hallmarks of this feeding assay, as it accommodates various experimental permutations across multiple infection durations. Typically, studies span up to ten days or continue until all virulent infection-challenged flies succumb. This adaptability facilitates both acute and longer-term infection studies, offering insights across temporal disease progressions. Moreover, the ability to assess bacterial loads and gut physiology within two days per time point streamlines data acquisition without sacrificing depth.

Another layer of sophistication emerges in the protocol’s capacity to introduce co-infections, enabling studies of microbial interactions within the host environment. By allowing simultaneous infection with multiple bacterial species, researchers can explore competitive dynamics, synergy in virulence, or modulation of host immunity by bacterial communities. This complexity mirrors polymicrobial infections encountered in clinical practice, positioning Drosophila as a versatile and relevant proxy for human disease.

The impact of this protocol extends beyond academic curiosity; it directly informs clinical and therapeutic strategies against Pseudomonas aeruginosa, a pathogen infamous for multi-drug resistance and opportunistic infections. By unraveling host-pathogen dialogue in a genetically tractable and experimentally amenable organism, the feeding infection model accelerates discovery of novel antimicrobial targets and host-centric therapies that enhance barrier integrity and immune defense.

Importantly, this approach ushers in refined ethical research practices by reducing the reliance on mammalian models in early infection studies. The Drosophila feeding infection protocol exemplifies the principles of reduction and refinement, providing robust mechanistic insights while adhering to high standards of animal welfare. As a result, it holds promise to reshape infection biology research paradigms, marrying scientific rigor with ethical responsibility.

Incorporating both classical microbiological expertise and modern molecular techniques, the protocol stands out as a comprehensive framework for dissecting the multifactorial nature of gut infections. Its design anticipates variabilities inherent to both host and pathogen, offering researchers a powerful tool to dissect complex infection biology with fine resolution.

Ultimately, this groundbreaking protocol invites the scientific community to harness the power of simplicity and innovation through Drosophila. By faithfully recapitulating Pseudomonas aeruginosa intestinal infection via feeding, it opens avenues for discoveries that transcend model boundaries, illuminating pathways toward mitigating the burden of infectious diseases in humans.

Subject of Research: Drosophila melanogaster as a model organism for studying intestinal infections caused by Pseudomonas aeruginosa.

Article Title: Drosophila melanogaster as a model host for studying Pseudomonas aeruginosa feeding infection.

Article References:
Pitsouli, C., Apidianakis, Y. Drosophila melanogaster as a model host for studying Pseudomonas aeruginosa feeding infection. Nat Protoc (2026). https://doi.org/10.1038/s41596-025-01311-z

Image Credits: AI Generated

DOI: https://doi.org/10.1038/s41596-025-01311-z